Creating higher titer lentivirus with caffeine.

Human Gene Therapy
Brian L EllisMatthew H Porteus

Abstract

The use of lentiviral vectors extends from the laboratory, where they are used for basic studies in virology and as gene transfer vectors gene delivery, to the clinic, where clinical trials using these vectors for gene therapy are currently underway. Lentiviral vectors are useful for gene transfer because they have a large cloning capacity and a broad tropism. Although procedures for lentiviral vector production have been standardized, simple methods to create higher titer virus during production would have extensive and important applications for both research and clinical use. Here we present a simple and inexpensive method to increase the titer by 3- to 8-fold for both integration-competent lentivirus and integration-deficient lentivirus. This is achieved during standard lentiviral production by the addition of caffeine to a final concentration of 2-4 mM. We find that sodium butyrate, a histone deacetylase inhibitor shown previously to increase viral titer, works only ∼50% as well as caffeine. We also show that the DNA-PKcs (DNA-dependent protein kinase catalytic subunit) inhibitor NU7026 can also increase viral titer, but that the combination of caffeine and NU7026 is not more effective than caffeine alone. We show that the...Continue Reading

References

Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·H L MalechJ I Gallin
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Apr 3, 2004·Nucleic Acids Research·Wesley D BlockSusan P Lees-Miller
Mar 11, 2006·Current Biology : CB·Hui ChenMatthew D Weitzman
Aug 15, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·H Bobby GasparAdrian J Thrasher
Aug 3, 2007·The Journal of Clinical Investigation·Kerstin SchwarzwaelderChristof von Kalle
Nov 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Anton NeschadimJeffrey A Medin
Mar 13, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Daniela ZychlinskiChristopher Baum
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
May 23, 2009·PLoS Pathogens·Iñigo NarvaizaMatthew D Weitzman
Oct 23, 2009·Gene Therapy·M B Banasik, P B McCray

❮ Previous
Next ❯

Citations

Mar 5, 2014·The Journal of Clinical Investigation·Matthew W ParkerPeter B Bitterman
Apr 18, 2013·Expert Opinion on Biological Therapy·Maria Mercedes SeguraAlain Garnier
Jun 2, 2015·Immunology and Cell Biology·Mahmood Y BilalJon Cd Houtman
Jun 15, 2016·Molecular and Cellular Neurosciences·Chris M ValdezAsim A Beg
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haiying ChenLexin Wang
Apr 9, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Olivier HumbertHans-Peter Kiem
Mar 18, 2017·Scientific Reports·John R CounsellOlivier Danos
Sep 20, 2017·Journal of Cellular Physiology·Jon RamseyC Matthew Kinsey
Nov 21, 2014·Nature Protocols·Gaetano GargiuloMaarten van Lohuizen
Apr 21, 2011·Expert Review of Anti-infective Therapy·Jean-Michel Garcia, Jimmy C C Lai
Mar 3, 2017·Scientific Reports·John R CounsellOlivier Danos
Oct 13, 2018·Scientific Reports·Naoto SuzukiShoji Yamaoka
Mar 27, 2018·Applied Microbiology and Biotechnology·Javier FuenmayorFrancesc Gòdia
Nov 25, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·Liqiong GuiLaura E Niklason
Sep 2, 2017·Scientific Reports·Jean-François GélinasStephen C Hyde
Jul 19, 2019·Cancer Research·Toshiro Hara, Inder M Verma
Feb 13, 2021·Viruses·Christopher Perry, Andrea C M E Rayat
Jun 12, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Li PanHaiying Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
flow cytometry

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

BioHub - Researcher Network

The Chan-Zuckerberg Biohub aims to support the fundamental research and develop the technologies that will enable physicians to cure, prevent, or manage all diseases in our childrens' lifetimes. The CZ Biohub brings together researchers from UC Berkeley, Stanford, and UCSF. Find the latest research from the CZ Biohub researcher network here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.